Premium
Sacral nerve stimulation can be an effective treatment for low anterior resection syndrome
Author(s) -
Eftaiha S. M.,
Balachandran B.,
Marecik S. J.,
Mellgren A.,
Nordenstam J.,
Melich G.,
Prasad L. M.,
Park J. J.
Publication year - 2017
Publication title -
colorectal disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.029
H-Index - 89
eISSN - 1463-1318
pISSN - 1462-8910
DOI - 10.1111/codi.13701
Subject(s) - medicine , surgery , stimulation , resection , sacral nerve stimulation , retrospective cohort study , fecal incontinence , implant
Aim Sacral nerve stimulation has become a preferred method for the treatment of faecal incontinence in patients who fail conservative (non‐operative) therapy. In previous small studies, sacral nerve stimulation has demonstrated improvement of faecal incontinence and quality of life in a majority of patients with low anterior resection syndrome. We evaluated the efficacy of sacral nerve stimulation in the treatment of low anterior resection syndrome using a recently developed and validated low anterior resection syndrome instrument to quantify symptoms. Method A retrospective review of consecutive patients undergoing sacral nerve stimulation for the treatment of low anterior resection syndrome was performed. Procedures took place in the Division of Colon and Rectal Surgery at two academic tertiary medical centres. Pre‐ and post‐treatment Cleveland Clinic Incontinence Scores and Low Anterior Resection Syndrome scores were assessed. Results Twelve patients (50% men) suffering from low anterior resection syndrome with a mean age of 67.8 (±10.8) years underwent sacral nerve test stimulation. Ten patients (83%) proceeded to permanent implantation. Median time from anterior resection to stimulator implant was 16 (range 5–108) months. At a median follow‐up of 19.5 (range 4–42) months, there were significant improvements in Cleveland Clinic Incontinence Scores and Low Anterior Resection Syndrome scores ( P < 0.001). Conclusion Sacral nerve stimulation improved symptoms in patients suffering from low anterior resection syndrome and may therefore be a viable treatment option.